Korean Circulation Journal

  • 제48권2호
  • /
  • Pages.168-169
  • /
  • 2018
  • /
  • 1738-5520(pISSN)
  • /
  • 1738-5555(eISSN)
대한심장학회 (The Korean Society of Cardiology)
권호 표지
DOI QR코드

DOI QR Code

Clinical Significance of Newly Diagnosed Diabetes Mellitus in the Era of DES for Acute Myocardial Infarction

  • Park, Hun-Jun (Division of Cardiology, The Catholic University of Korea College of Medicine, Cardiovascular Center, Seoul St. Mary's Hospital)
  • 투고 : 2018.01.04
  • 심사 : 2018.01.25
  • 발행 : 2018.02.28
⟨ 이전 논문 다음 논문 ⟩

초록

키워드

참고문헌

  1. Park HW, Yoon CH, Kang SH, et al. Early- and late-term clinical outcome and their predictors in patients with ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction. Int J Cardiol 2013;169:254-61. https://doi.org/10.1016/j.ijcard.2013.08.132
  2. Norhammar A, Malmberg K, Diderholm E, et al. Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization. J Am Coll Cardiol 2004;43:585-91. https://doi.org/10.1016/j.jacc.2003.08.050
  3. Park HW, Kang MG, Kim K, et al. Long-term prognosis and clinical characteristics of patients with newly diagnosed diabetes mellitus detected after the first acute myocardial infarction: from the KAMIR-NIH registry. Korean Circ J. 2018;48:134-47. https://doi.org/10.4070/kcj.2017.0174
  4. Aguilar D, Solomon SD, Kober L, et al. Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial. Circulation 2004;110:1572-8. https://doi.org/10.1161/01.CIR.0000142047.28024.F2
  5. Ertelt K, Brener SJ, Mehran R, Ben-Yehuda O, McAndrew T, Stone GW. Comparison of outcomes and prognosis of patients with versus without newly diagnosed diabetes mellitus after primary percutaneous coronary intervention for ST-elevation myocardial infarction (the HORIZONS-AMI Study). Am J Cardiol 2017;119:1917-23. https://doi.org/10.1016/j.amjcard.2017.03.016
  6. Standards of medical care in diabetes-2016: summary of revisions. Diabetes Care 2016;39 Suppl 1:S4-5. https://doi.org/10.2337/dc16-S003
  7. Chamberlain JJ, Rhinehart AS, Shaefer CF Jr, Neuman A. Diagnosis and management of diabetes: synopsis of the 2016 American Diabetes Association standards of medical care in diabetes. Ann Intern Med 2016;164:542-52. https://doi.org/10.7326/M15-3016
  8. Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol 2011;58:e44-122. https://doi.org/10.1016/j.jacc.2011.08.007
  9. Stefanini GG, Holmes DR Jr. Drug-eluting coronary-artery stents. N Engl J Med 2013;368:254-65. https://doi.org/10.1056/NEJMra1210816
  10. Bangalore S, Kumar S, Fusaro M, et al. Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22,844 patient years of follow-up from randomised trials. BMJ 2012;345:e5170. https://doi.org/10.1136/bmj.e5170